Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.
about
Association between consumption of dairy products and incident type 2 diabetes--insights from the European Prospective Investigation into Cancer studyPlasma phospholipid fatty acid profile confirms compliance to a novel saturated fat-reduced, monounsaturated fat-enriched dairy product intervention in adults at moderate cardiovascular risk: a randomized controlled trialInteraction between genes and macronutrient intake on the risk of developing type 2 diabetes: systematic review and findings from European Prospective Investigation into Cancer (EPIC)-InterAct.The development and validation of a fast and robust dried blood spot based lipid profiling method to study infant metabolism.Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study.Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesityHexadecenoic Fatty Acid Isomers in Human Blood Lipids and Their Relevance for the Interpretation of Lipidomic Profiles.Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.A combination of plasma phospholipid fatty acids and its association with incidence of type 2 diabetes: The EPIC-InterAct case-cohort study.The EPIC-InterAct Study: A Study of the Interplay between Genetic and Lifestyle Behavioral Factors on the Risk of Type 2 Diabetes in European Populations.Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: a cross-sectional analysis in the EPIC-InterAct study.Association between Erythrocyte Membrane Phospholipid Fatty Acids and Sleep Disturbance in Chinese Children and Adolescents.
P2860
Q26801737-7F099B59-B324-4489-9973-4728BFF87422Q33721755-1D458EAD-3D80-43C6-8522-1161715F7FDCQ33839290-44B4C28F-411A-48AD-80B7-15127E629B5EQ34091272-BB26B156-2311-4C92-8A43-5A3F38DC25D6Q34334832-EB9C7920-8390-4CB1-B02A-B3A234A8E031Q34362178-7B28F0CA-EB16-4A2B-B5AE-74CC667F13BDQ35979724-B728F96A-BA13-4317-8802-9C9E6C8CD7ECQ36081622-03BD72AD-A37B-4E7B-A3C2-3F74C10B674AQ42705334-54394964-883B-4A25-80B7-914E8CAE2E0BQ42973869-1B822DE6-930F-44EA-BF1D-116ABE35BC23Q47336123-DBB3041C-1273-49D1-B403-FD5FAFD41064Q55365351-B025F265-1BAF-476E-843B-9F8CF63DD005
P2860
Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Development and validation of ...... large epidemiological studies.
@en
type
label
Development and validation of ...... large epidemiological studies.
@en
prefLabel
Development and validation of ...... large epidemiological studies.
@en
P2093
P2860
P356
P1433
P1476
Development and validation of ...... large epidemiological studies.
@en
P2093
Carmen Rodriguez-Canas
Ian Mather
Keith Summerhill
Laura Yun Wang
Michael Eiden
Pinal Patel
Stephen Young
P2860
P2888
P356
10.1186/GM443
P577
2013-04-25T00:00:00Z
P5875
P6179
1007631503